What is The Precision Peptide Company Inc (PNGAF) stock price today?

The Precision Peptide Company Inc (PNGAF) is currently trading at $0.33, up 1.43% today.

What is PNGAF P/E ratio?

The Precision Peptide Company Inc's P/E ratio is -2.32. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PNGAF return on equity (ROE)?

The Precision Peptide Company Inc's return on equity (ROE) is -241.90%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is The Precision Peptide Company Inc's market cap?

The Precision Peptide Company Inc has a market capitalization of $5.07M.

OTC · Packaged Foods

The Precision Peptide Company Inc (PNGAF) Stock

$0.33 +1.43% OTC: PNGAF Consumer Defensive

Operating across both Canadian and U.S. markets, Pangea Natural Foods Inc.

Valuation

Metric	Value
Price	$0.33
Market Cap	$5.07M
P/E Ratio	-2.32
P/B Ratio	13.15
P/S Ratio	184.53
EPS (TTM)	$-0.21
52-Week High	$0.50
52-Week Low	$0.01
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-241.90%
ROA	-343.79%
ROCE	-242.22%
Gross Margin	-48.83%
Operating Margin	—
Net Margin	—
Debt/Equity	0.00
Current Ratio	3.32

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$1.0M	$0	$0	$0
Operating Profit	$0	$-1.0M	$-2.0M	$-1.0M	$-2.0M
Net Profit	$0	$-2.0M	$-2.0M	$-1.0M	$-5.0M
EPS	$-0.01	$-0.04	$-0.05	$-0.15	$-0.21
Op Margin	-252.9%	-95.0%	-575.4%	-7545.5%	-4530.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$1.0M	$0	$0	$1.0M
Total Liabilities	$0	$0	$0	$1.0M	$0
Cash	$1.0M	$0	$0	$0	$1.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review TMX Newsfile · Jul 30, 2026 The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support TMX Newsfile · Jul 28, 2026 The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV TMX Newsfile · Jul 24, 2026 The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch TMX Newsfile · Jul 21, 2026 The Precision Peptide Company Raises C$2 Million Via LIFE Offering MT Newswires · Jul 15, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$-2.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$0	$0	$0	$0
Net Cash Flow	$1.0M	$-1.0M	$0	$0	$1.0M
Free Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.02
EV / EBITDA	-3.75
FCF Yield	-21.26%
Quick Ratio	3.14
Interest Coverage	0.00
Return 1Y	43.31%
Return 3Y	-44.99%
Return 5Y	—

Ownership

Insiders Held2.54%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AIXNAiXin Life International, Inc.	$0.26	+0.00%	-3.18	$6.50M	0.00%
ARRTArtisan Consumer Goods, Inc.	$0.21	+0.00%	-25.54	$932810	0.00%
CEUMFCentury Global Commodities Corporation	$0.10	+0.00%	-7.69	$12.29M	0.00%
CLGOFCleanGo Innovations Inc.	$0.96	+3.31%	-5.98	$7.70M	0.00%
EWLUMerion, Inc.	$0.00	—	-0.01	$6229	0.00%

About The Precision Peptide Company Inc

Operating across both Canadian and U.S. markets, Pangea Natural Foods Inc. is primarily involved in the creation and sale of plant-based food alternatives. Their product line includes various types of plant-based patties, an item they refer to as Old Fashioned Ghee (a butter product), and vegan Chickn' bites, which are designed as a plant-based nugget option. The company ensures its products reach consumers through multiple channels, leveraging online e-commerce platforms, traditional retail stores, and robust wholesale distribution networks. Initially founded in 2021 as Plant-Faced Foods Ltd., the firm officially adopted its current name, Pangea Natural Foods Inc., in September 2021. Its corporate headquarters are located in Surrey, Canada.

The Precision Peptide Company Inc is headquartered in CA.

The Precision Peptide Company Inc (PNGAF) stock trades at $0.33 with a market capitalization of $5.07M. The stock is valued at a price-to-earnings (P/E) ratio of -2.32, price-to-book of 13.15, price-to-sales of 184.53. Over the past 52 weeks the stock has ranged between $0.01 and $0.50, and currently trades 34.0% below its 52-week high.

On profitability, The Precision Peptide Company Inc generates a return on equity (ROE) of -241.90%, return on capital employed of -242.22%.

Official website: www.pangeafood.com